Lab Information
Alexander Lawandi (MD/MSc)
Junior ScientistCentre for Translational Biology
Department of Medicine (McGill)
Research Profile
Keywords
Team Members
| Name | Position |
|---|
Latest Publications
- Lieu, A., Harrison, L. B., Harel, J., Lawandi, A., Cheng, M. P. & Domingo, M.--. C. (2024). The microbiological outcomes of culture-negative blood specimens using 16S rRNA broad-range PCR sequencing: a retrospective study in a Canadian province from 2018 to 2022. Journal of clinical microbiology, vol. 62, p. e0151823.
- Lawandi, A., Oshiro, M., Warner, S., Diao, G., Strich, J. R., Babiker, A., Rhee, C., Klompas, M., Danner, R. L. & Kadri, S. S. (2024). The authors reply. Critical care medicine, vol. 52, p. e31-e33.
- Lieu, A., Lee, T. C., Lawandi, A., Tellier, R., Cheng, M. P. & Dufresne, P. J. (2023). Microbiological characterization of Pneumocystis jirovecii pneumonia using quantitative PCR from nasopharyngeal specimens: a retrospective study in a Canadian province from 2019 to 2023. Journal of clinical microbiology, p. e0091323.
- Del Corpo, O., Senécal, J., Hsu, J. M., Lawandi, A. & Lee, T. C. (2023). Rapid phenotypic testing for detection of carbapenemase- or extended spectrum ß-lactamase-producing Enterobacterales directly from blood cultures: A systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 29, p. 1516-1527.
- Lawandi, A. (2023). Bloodstream Infections in Sepsis: Better the Devil You Know. Critical care medicine, vol. 51, p. 1261-1263.
- Cheng, M. P., Paquette, K., Lawandi, A., Stabler, S. N., Akhter, M., Davidson, A. C., Gavric, M., Jinah, R., Saeed, Z., Demir, K., Sangsari, S., Huang, K., Mahpour, A., Shamatutu, C., Caya, C., Troquet, J.-M., Clark, G., Rush, B., Wong, T., Stenstrom, R., Sweet, D. & Yansouni, C. P. (2022). qSOFA does not predict bacteremia in patients with severe manifestations of sepsis. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, vol. 7, p. 364-368.
- Lawandi, A., Oshiro, M., Warner, S., Diao, G., Strich, J. R., Babiker, A., Rhee, C., Klompas, M., Danner, R. L. & Kadri, S. S. (2023). Reliability of Admission Procalcitonin Testing for Capturing Bacteremia Across the Sepsis Spectrum: Real-World Utilization and Performance Characteristics, 65 U.S. Hospitals, 2008-2017. Critical care medicine, vol. 51, p. 1527-1537.
- Sohani, Z. N., Butler-Laporte, G., Aw, A., Belga, S., Benedetti, A., Carignan, A., Cheng, M. P., Coburn, B., Costiniuk, C. T., Ezer, N., Gregson, D., Johnson, A., Khwaja, K., Lawandi, A., Leung, V., Lother, S., MacFadden, D., McGuinty, M., Parkes, L., Qureshi, S., Roy, V., Rush, B., Schwartz, I., So, M., Somayaji, R., Tan, D., Trinh, E., Lee, T. C. & McDonald, E. G. (2022). Low-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trial. BMJ open, vol. 12, p. e053039.
- McDonald, E. G., Butler-Laporte, G., Del Corpo, O., Hsu, J. M., Lawandi, A., Senecal, J., Sohani, Z. N., Cheng, M. P. & Lee, T. C. (2021). On the Treatment of Pneumocystis jirovecii Pneumonia: Current Practice Based on Outdated Evidence. Open forum infectious diseases, vol. 8, p. ofab545.
- Lee, T. C., Wilson, M. G., Lawandi, A. & McDonald, E. G. (2021). The Reply. The American journal of medicine, vol. 134, p. e536-e537.
See also
